Centese

Omaha, NE · Founded 2015 · Privately Held (backing)

Developer of advanced post-operative surgical drainage designed to address expensive and frequent complications in open-heart or open-lung surgery. Centese is based in Omaha, NE and was founded in 2015. Its last reported valuation was $40.1 million in Nov 2023. It has raised $30.5 million across 3 recorded rounds; the latest was a $250,000 seed round in May 2026.

Last reported valuation
$40.1M
Oct 2026
Priced at
—
Total raised
$30.5M
Last round
Seed Round
May 2026

Who backs Centese?

17 investors
InvestorType
US National Science FoundationOther
New York AngelsAngel
Invest NebraskaVenture capital
Barshop VenturesFamily office
Accuryn—
Blake Hoogeveen—
Ehrenberg Chesler Investment Bankers—
Green Park & Golf Ventures—
HBS Alumni Angels of Greater New York—
Houston Angel Network—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Centese investors

17 investors are on record for Centese, including US National Science Foundation, New York Angels, Invest Nebraska and Barshop Ventures. The seed round in May 2026 drew 1 investor.

Free account
More of Centese with a free account
  • ·The complete investor list: 17 names
  • ·Watch Centese: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Centese. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View